Literature DB >> 81809

Antitumor activity of mycobacterial glycolipid A1.

Z Reggiardo.   

Abstract

Glycolipid A1 isolated from Mycobacterium bovis BCG, when dissolved in olive oil and injected together with Line 10 transplantable hepatoma cells, is able to elicit a host response which results in the abrogation or retardation of tumor growth in syngeneic guinea pigs. Glycolipid A1 does not have adjuvant activity for delayed type hypersensitivity, and antibodies to A1 have not been detected in the sera of guinea pigs during or after the tumor abrogation induced by A1 injection Glycolipid A1 does not share antigenic determinants with Line 10 cell lipid fractions. The possible role of the granuloma response elicited by A1 in controlling tumor growth is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81809      PMCID: PMC422083          DOI: 10.1128/iai.21.3.914-917.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Chemotactic response of leukocytes to cord factor (trehalose-6,6'-dimycolate).

Authors:  I Ofek; A Bekierkunst
Journal:  J Natl Cancer Inst       Date:  1976-12       Impact factor: 13.506

2.  Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.

Authors:  M T Kelly
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Adjuvant effect of cord factor, a mycobacterial lipid.

Authors:  R Saito; A Tanaka; K Sugiyama; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

4.  Biologically active components from mycobacterial cell walls. V. Granuloma formation in mouse lungs and guinea pig skin.

Authors:  T J Meyer; E Ribi; I Azuma
Journal:  Cell Immunol       Date:  1975-03       Impact factor: 4.868

5.  Monitoring immunotherapy with serologically active glycolipid fractions of BCG.

Authors:  A G Wile; Z Reggiardo; F C Sparks; D L Morton
Journal:  Surg Forum       Date:  1976

6.  Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets.

Authors:  D L Granger; K I Yamamoto; E Ribi
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

7.  Tumor regression caused by endotoxins and mycobacterial fractions.

Authors:  E E Ribi; D L Granger; K C Milner; S M Strain
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

8.  Granulomagenic activity of serologically active glycolipids from Mycobacterium bovis BCG.

Authors:  Z Reggiardo; A K Shamsuddin
Journal:  Infect Immun       Date:  1976-12       Impact factor: 3.441

9.  Stimulation of macrophages by cord factor and by heat-killed and living BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Serologically active glycolipid families from Mycobacterium bovis BCG. II. Serologic studies on human sera.

Authors:  Z Reggiardo; G Middlebrook
Journal:  Am J Epidemiol       Date:  1974-12       Impact factor: 4.897

View more
  2 in total

1.  Cerebroside sulfotransferase: preparation of antibody and localization of antigen in kidney.

Authors:  G I Tennekoon; J Frangia; S Aitchison; D L Price
Journal:  J Cell Biol       Date:  1981-11       Impact factor: 10.539

2.  Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment.

Authors:  Estela Noguera-Ortega; Núria Blanco-Cabra; Rosa Maria Rabanal; Alejandro Sánchez-Chardi; Mónica Roldán; Sandra Guallar-Garrido; Eduard Torrents; Marina Luquin; Esther Julián
Journal:  Sci Rep       Date:  2016-06-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.